Characteristics of patients with isolated systolic hypertension in relation to the body mass index;Caractéristiques des patients avec une HTA systolique isolée en fonction de la masse corporelle

Archives des Maladies du Coeur et des Vaisseaux

Volumn 95, Issue 7-8, 2002, Pages 683-686

  Denolle, T ^a   Gallois, H ^a   L'Hostis, P ^a   Cimarosti, I ^a  

^a Hôpital La Providence Gardiner   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANAMNESIS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; QUESTIONNAIRE; RISK MANAGEMENT; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

AGED; BODY MASS INDEX; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RISK FACTORS; SYSTOLE;

EID: 0036656810     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Kannel WB, Garrison RJ, Dannenberg AL. Seculer blood pressure trends in normatensive persons: the Framingham Study. Am Heart J 1993; 125: 1154-8.
2. Van Itallie TB. Health implications of overweight and obesity in the United States. Ann Intern Med 1985; 103: 983-8.
3. Raison J, Pannier B, Blather J et Safar M. HTA et corpulence. Arch Mal Cœur 2000; 93: 1423-8.
4. Scherrer U, Sartori C. Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity and cardiovascular morbidity. Circulation 1997; 96: 4104-13.
5. Levy D, Garrison RJ, Savage DD et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-6.
6. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. Lancet 2001; 357: 972-3.
7. Management of patients with essential hypertension. Clinical recommendations and economic data. Guidelines April 2000. Recommendations of the ANAES. J Mal Vasc 2000; 25: 366-76.
8. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991; 265: 3255-64.
9. Staessen JA, Fagard R, Thijs L et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350: 757-64.
10. Liu L, Wang JG, Gong L, Liu G, Staessen JA, for the Systolic Hypertension in Chino (Syst-China) Collaborative Group. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. J Hypertens 1998; 16: 1823-29.